APA (7th ed.) Citation

Goulden, S., Shen, Q., Coleman, R. L., Mathews, C., Hunger, M., Pahwa, A., & Schade, R. Outcomes for Dostarlimab and Real-World Treatments in Post-platinum Patients With Advanced/Recurrent Endometrial Cancer: The GARNET Trial Versus a US Electronic Health Record-Based External Control Arm. Columbia Data Analytics, LLC.

Chicago Style (17th ed.) Citation

Goulden, Scott, Qin Shen, Robert L. Coleman, Cara Mathews, Matthias Hunger, Ankit Pahwa, and Rene Schade. Outcomes for Dostarlimab and Real-World Treatments in Post-platinum Patients With Advanced/Recurrent Endometrial Cancer: The GARNET Trial Versus a US Electronic Health Record-Based External Control Arm. Columbia Data Analytics, LLC.

MLA (9th ed.) Citation

Goulden, Scott, et al. Outcomes for Dostarlimab and Real-World Treatments in Post-platinum Patients With Advanced/Recurrent Endometrial Cancer: The GARNET Trial Versus a US Electronic Health Record-Based External Control Arm. Columbia Data Analytics, LLC.